17-DMAG (17-Dimethylaminoethylamino-17-Demethoxygeldanamycin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 17-DMAG (17-Dimethylaminoethylamino-17-Demethoxygeldanamycin), covering 2012-03-15 to 2013-08-02. Get the full timeline:
Most recent: Clinical Trial Update: 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery [Phase 1]